Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials for Zealand Pharma
Explore 9 clinical trials worldwide
Search
Showing 1-9 of 9 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Sponsor: Zealand Pharma
Clinical Trials (9)
NCT07197944
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
PHASE3
Not yet recruiting
90 participants
Started: Oct 23, 2025 · Completed: Feb 28, 2032
1 condition
1 sponsor
0 locations
NCT06926842
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)
PHASE2
Recruiting
216 participants
Started: Apr 22, 2025 · Completed: Jun 4, 2026
3 conditions
2 sponsors
25 locations
NCT07076030
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
PHASE1
Recruiting
48 participants
Started: Apr 15, 2025 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06662539
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
PHASE2
Active, not recruiting
494 participants
Started: Dec 9, 2024 · Completed: Mar 16, 2026
1 condition
2 sponsors
32 locations
NCT06682975
A Research Study Looking at the Safety of Single Doses of ZP9830 and How it Works in the Body of Healthy Participants
PHASE1
Recruiting
92 participants
Started: Nov 12, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05788601
Dapiglutide for the Treatment of Obesity
PHASE2
Active, not recruiting
54 participants
Started: Apr 27, 2023 · Completed: Aug 15, 2025
2 conditions
2 sponsors
1 location
NCT04881825
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
PHASE3
Enrolling by invitation
129 participants
Started: Jun 16, 2021 · Completed: Apr 30, 2025
1 condition
1 sponsor
19 locations
NCT03905707
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
PHASE3
Active, not recruiting
145 participants
Started: May 7, 2019 · Completed: Oct 31, 2026
1 condition
1 sponsor
27 locations
NCT03941236
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism
PHASE3
Active, not recruiting
44 participants
Started: May 1, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
10 locations